NCT03637582

Brief Summary

The purpose of this study is to evaluate how urethral anesthesia impacts voiding efficiency in healthy women. The investigator hypothesizes that anesthetizing the urethral with lidocaine gel will decrease voiding efficiency as measured by standard bladder testing (urodynamic testing).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 20, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

November 26, 2018

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2018

Completed
Last Updated

November 14, 2019

Status Verified

January 1, 2019

Enrollment Period

25 days

First QC Date

August 16, 2018

Last Update Submit

November 12, 2019

Conditions

Keywords

voiding efficiencydetrusor underactivityurodynamics

Outcome Measures

Primary Outcomes (1)

  • Voiding Efficiency

    voided volume/{voided volume + residual volume} during micturition study during urodynamic studies

    duration of urodynamic study, 2 hours

Secondary Outcomes (3)

  • Detrusor pressure at maximum flow

    duration of urodynamic study, 2 hours

  • Presence or absence of voiding dysfunction

    duration of urodynamic study, 2 hours

  • Visual analog scale scores

    duration of urodynamic study, 2 hours

Study Arms (2)

Anesthesia Arm

ACTIVE COMPARATOR

Participants randomized to this arm will undergo uroflow studies then be given an hour rest. Five ml of 4% lidocaine gel will be inserted into the urethra during their hour rest. After the incubation period, the subject will receive another five ml of 4% lidocaine gel. The subject will then perform the second uroflow study. Complex urodynamics with the use of lidocaine hydrochloride 4% will then be performed. The lidocaine gel will have been placed in and around the urethra. We are using lidocaine gel in an FDA approved manner (for anesthesia).

Drug: lidocaine gel

Placebo Arm

PLACEBO COMPARATOR

Participants randomized to this arm will first undergo uroflow studies then be given an hour rest. Five ml of plain aqueous gel will be inserted into the urethra during their hour rest. After the incubation period, the subject will receive another five ml of plain aqueous gel. Urodynamic testing without anesthesia (standard of care) will then be performed.

Other: Plain aqueous gel

Interventions

Lidocaine (4%) gel from Quest Products, Inc.

Also known as: 4% lidocaine
Anesthesia Arm

KY jelly lubricant from Reckitt Benckiser

Also known as: KY gel
Placebo Arm

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Females ages 18-60 years

You may not qualify if:

  • Able to provide informed consent and agree to the risks of the study
  • Willing to abstain from caffeine and alcohol for 24 hours
  • Willing to avoid taking anticholinergic medications (for reasons other than incontinence; e.g., diphenhydramine) for one week prior to the procedure
  • Pelvic organ prolapse past the hymen
  • Multiple sclerosis, myasthenia gravis, Parkinson's Disease, stroke within the past 6 months
  • Interstitial cystitis / Bladder Pain Syndrome
  • Recurrent (≥ 3/year) urinary tract infections
  • Positive pregnancy test at the time of consent
  • Positive urine dip (\>+1nitrites or \>1+LE) and urinary symptoms at the time of consent
  • \>1+ blood on urinary dip
  • Morbid obesity (BMI \>40)
  • Taking anticholinergic medications for urinary incontinence
  • \>2 replies of ≥ "sometimes" on the Lower Urinary Tract Symptoms questionnaire at the time of consent
  • Alcoholism or failed CAGE questionnaire
  • Abnormal baseline uroflow
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Campus

Durham, North Carolina, 27708, United States

Location

Related Publications (5)

  • Chen SC, Grill WM, Fan WJ, Kou YR, Lin YS, Lai CH, Peng CW. Bilateral pudendal afferent stimulation improves bladder emptying in rats with urinary retention. BJU Int. 2012 Apr;109(7):1051-8. doi: 10.1111/j.1464-410X.2011.10526.x. Epub 2011 Aug 23.

    PMID: 21883860BACKGROUND
  • Peng CW, Chen JJ, Cheng CL, Grill WM. Improved bladder emptying in urinary retention by electrical stimulation of pudendal afferents. J Neural Eng. 2008 Jun;5(2):144-54. doi: 10.1088/1741-2560/5/2/005. Epub 2008 Apr 22.

    PMID: 18430976BACKGROUND
  • Shafik A, Shafik AA, El-Sibai O, Ahmed I. Role of positive urethrovesical feedback in vesical evacuation. The concept of a second micturition reflex: the urethrovesical reflex. World J Urol. 2003 Aug;21(3):167-70. doi: 10.1007/s00345-003-0340-5. Epub 2003 Jul 25.

    PMID: 12898170BACKGROUND
  • Kisby CK, Gonzalez EJ, Visco AG, Amundsen CL, Grill WM. Randomized Controlled Trial to Assess the Impact of Intraurethral Lidocaine on Urodynamic Voiding Parameters. Female Pelvic Med Reconstr Surg. 2019 Jul/Aug;25(4):265-270. doi: 10.1097/SPV.0000000000000544.

    PMID: 29300256BACKGROUND
  • McKee DC, Gonzalez EJ, Amundsen CL, Grill WM. Randomized Controlled Trial to Assess the Impact of High Concentration Intraurethral Lidocaine on Urodynamic Voiding Parameters. Urology. 2019 Nov;133:72-77. doi: 10.1016/j.urology.2019.08.020. Epub 2019 Aug 26.

MeSH Terms

Conditions

Urinary Bladder, Underactive

Interventions

Lidocaine

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Warren M Grill, PhD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2018

First Posted

August 20, 2018

Study Start

November 26, 2018

Primary Completion

December 21, 2018

Study Completion

December 21, 2018

Last Updated

November 14, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations